Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-12-16 | McGuire Annie | SVP, General Counsel | Sell | 10,739 | $43.13 | $463,203.60 | -7.3% | → |
| 2025-12-05 | EASTHAM KARIN | Director | Sale+OE | 20,000 | $45.45 | $908,923.34 | -26.6% | → |
| 2025-12-04 | Stapley Marc | Chief Executive Officer | Sell | 7,668 | $47.09 | $361,075.59 | -1.2% | → |
| 2025-12-04 | Chambers Rebecca | Chief Financial Officer | Sell | 13,278 | $46.84 | $621,955.21 | -5.6% | → |
| 2025-12-04 | McGuire Annie | SVP, General Counsel | Sell | 1,422 | $47.30 | $67,260.78 | -0.9% | → |
| 2025-12-04 | Leite John | Chief Commercial Officer-CLIA | Sell | 1,278 | $47.51 | $60,717.78 | -1.5% | → |
| 2025-11-25 | Leite John | Chief Commercial Officer-CLIA | Sell | 2,808 | $50.00 | $140,400.00 | -3.2% | → |
| 2025-11-25 | JONES EVAN/ FA | Director | Sell | 1,106 | $50.25 | $55,575.73 | -3.6% | → |
| 2025-11-20 | Holstein Jens | Director | Sell | 10,000 | $42.36 | $423,563.05 | -9.8% | → |
| 2025-11-10 | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 10,920 | $41.20 | $449,907.35 | -11.7% | → |
| 2025-11-05 | McGuire Annie | SVP, General Counsel | Sell | 6,466 | $40.00 | $258,640.00 | -7.2% | → |
| 2025-11-05 | JONES EVAN/ FA | Director | Sale+OE | 43,196 | $45.06 | $1,946,287.73 | -11.8% | → |
| 2025-11-05 | Chambers Rebecca | Chief Financial Officer | Sell | 7,000 | $41.00 | $287,000.00 | -5.3% | → |
| 2025-11-05 | EASTHAM KARIN | Director | Sell | 9,674 | $40.02 | $387,191.21 | -41.6% | → |
| 2025-10-06 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 8,349 | $36.02 | $300,709.27 | -8.3% | → |
| 2025-10-01 | EPSTEIN ROBERT S | Director | Sale+OE | 21,473 | $35.08 | $753,204.13 | -25.6% | → |
| 2025-10-01 | McGuire Annie | SVP, General Counsel | Sell | 2,160 | $35.00 | $75,607.56 | -2.4% | → |
| 2025-10-01 | Leite John | Chief Commercial Officer-CLIA | Sell | 2,539 | $35.00 | $88,865.00 | -2.8% | → |
| 2025-09-19 | McGuire Annie | SVP, General Counsel | Sell | 2,283 | $33.69 | $76,919.52 | -2.4% | → |
| 2025-09-04 | Stapley Marc | Chief Executive Officer | Sell | 7,667 | $30.41 | $233,132.77 | -2.2% | → |
| 2025-06-13 | Bhanji Muna | Director | Sell | 4,589 | $26.67 | $122,366.60 | -13.3% | → |
| 2025-06-13 | EASTHAM KARIN | Director | Sell | 4,590 | $26.66 | $122,387.76 | -24.8% | → |
| 2025-06-04 | Leite John | Chief Commercial Officer-CLIA | Sell | 2,809 | $27.20 | $76,409.86 | -2.9% | → |
| 2025-03-07 | Leite John | Chief Commercial Officer-CLIA | Sell | 7,411 | $31.66 | $234,629.55 | -3.5% | → |
| 2025-03-04 | Stapley Marc | Chief Executive Officer | Sell | 52,697 | $33.34 | $1,756,855.23 | -6.0% | → |
| 2025-03-04 | McGuire Annie | SVP, General Counsel | Sell | 1,142 | $33.69 | $38,476.49 | -1.6% | → |
| 2025-03-04 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 8,037 | $33.35 | $268,012.94 | -4.5% | → |
| 2025-02-27 | Leite John | Chief Commercial Officer-CLIA | Sell | 5,746 | $33.84 | $194,444.64 | -6.8% | → |
| 2025-02-03 | Chambers Rebecca | Chief Financial Officer | Sell | 527 | $43.85 | $23,108.95 | -0.5% | → |
| 2025-01-02 | EASTHAM KARIN | Director | Sale+OE | 10,000 | $40.30 | $403,005.64 | -19.3% | → |
| 2024-12-13 | Stapley Marc | Chief Executive Officer | Sell | 400 | $44.14 | $17,656.52 | -0.1% | → |